191 related articles for article (PubMed ID: 23281009)
1. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
El-Shamy A; Shindo M; Shoji I; Deng L; Okuno T; Hotta H
Hepatology; 2013 Aug; 58(2):555-63. PubMed ID: 23281009
[TBL] [Abstract][Full Text] [Related]
2. Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance.
Akuta N; Suzuki F; Sezaki H; Kobayashi M; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30381417
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy.
El-Shamy A; Kim SR; Ide YH; Sasase N; Imoto S; Deng L; Shoji I; Hotta H
Intervirology; 2012; 55(1):1-11. PubMed ID: 21293098
[TBL] [Abstract][Full Text] [Related]
4. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.
Kumthip K; Pantip C; Chusri P; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
J Viral Hepat; 2011 Apr; 18(4):e117-25. PubMed ID: 20955493
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus 1b viral factors (core, NS3, and NS5A) and increased risk of hepatocellular carcinoma.
Sharma SD
Hepatology; 2013 Aug; 58(2):491-3. PubMed ID: 23471816
[No Abstract] [Full Text] [Related]
6. Polymorphisms of the NS3 Proteins of Hepatitis C Virus Genotype 1b Are Associated with Liver Cirrhosis.
Chen X; Gui X; Deng L; Ho WZ; Zhou L; Liu Z; Zheng S
AIDS Res Hum Retroviruses; 2016 Sep; 32(9):892-4. PubMed ID: 27118612
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.
Nishise Y; Saito T; Sugahara K; Ito JI; Saito K; Togashi H; Nagano-Fujii M; Hotta H; Kawata S
J Infect Dis; 2007 Oct; 196(7):1006-9. PubMed ID: 17763321
[TBL] [Abstract][Full Text] [Related]
8. Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.
El-Shamy A; Shoji I; Kim SR; Ide Y; Imoto S; Deng L; Yoon S; Fujisawa T; Tani S; Yano Y; Seo Y; Azuma T; Hotta H
PLoS One; 2012; 7(2):e30513. PubMed ID: 22319571
[TBL] [Abstract][Full Text] [Related]
9. Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.
El-Shamy A; Shoji I; Saito T; Watanabe H; Ide YH; Deng L; Kawata S; Hotta H
Microbiol Immunol; 2011 Jun; 55(6):418-26. PubMed ID: 21371092
[TBL] [Abstract][Full Text] [Related]
10. Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.
Seko Y; Akuta N; Suzuki F; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Intervirology; 2013; 56(1):13-21. PubMed ID: 22907167
[TBL] [Abstract][Full Text] [Related]
11. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
[TBL] [Abstract][Full Text] [Related]
12. Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients.
El-Shamy A; Pendleton M; Eng FJ; Doyle EH; Bashir A; Branch AD
Sci Rep; 2016 Jun; 6():27025. PubMed ID: 27246310
[TBL] [Abstract][Full Text] [Related]
13. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
[TBL] [Abstract][Full Text] [Related]
14. Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein.
Ogata S; Florese RH; Nagano-Fujii M; Hidajat R; Deng L; Ku Y; Yoon S; Saito T; Kawata S; Hotta H
J Clin Microbiol; 2003 Jul; 41(7):2835-41. PubMed ID: 12843009
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
16. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.
Sabri S; Idrees M; Rafique S; Ali A; Iqbal M
Int J Infect Dis; 2014 Aug; 25():38-44. PubMed ID: 24845365
[TBL] [Abstract][Full Text] [Related]
17. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
[TBL] [Abstract][Full Text] [Related]
18. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.
Le Guillou-Guillemette H; Ducancelle A; Bertrais S; Lemaire C; Pivert A; Veillon P; Bouthry E; Alain S; Thibault V; Abravanel F; Rosenberg AR; Henquell C; André-Garnier E; Petsaris O; Vallet S; Bour JB; Baazia Y; Trimoulet P; André P; Gaudy-Graffin C; Bettinger D; Larrat S; Signori-Schmuck A; Saoudin H; Pozzetto B; Lagathu G; Minjolle-Cha S; Stoll-Keller F; Pawlotsky JM; Izopet J; Payan C; Lunel-Fabiani F
J Clin Virol; 2015 Aug; 69():203-9. PubMed ID: 26209408
[TBL] [Abstract][Full Text] [Related]
19. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.
Ogata S; Nagano-Fujii M; Ku Y; Yoon S; Hotta H
J Clin Microbiol; 2002 Oct; 40(10):3625-30. PubMed ID: 12354856
[TBL] [Abstract][Full Text] [Related]
20. Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan.
Lee CM; Hung CH; Lu SN; Wang JH; Tung HD; Huang WS; Chen CL; Chen WJ; Changchien CS
Intervirology; 2006; 49(1-2):76-81. PubMed ID: 16166793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
